Global control of COVID-19: good vaccines may not suffice

被引:4
作者
Eslava-Schmalbach, Javier [1 ]
Rosero, Eric B. [2 ]
Garzon-Orjuela, Nathaly [1 ]
机构
[1] Univ Nacl Colombia, Bogota, Colombia
[2] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH | 2021年 / 45卷
关键词
Coronavirus infections; COVID-19; SARS-CoV-2; vaccines; immunity; herd; vaccination; health; HERD-IMMUNITY; ERADICATION;
D O I
10.26633/RPSP.2021.148
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The COVID-19 pandemic has unveiled health and socioeconomic inequities around the globe. Effective epidemic control requires the achievement of herd immunity, where susceptible individuals are conferred indirect protection by being surrounded by immunized individuals. The proportion of people that need to be vaccinated to obtain herd immunity is determined through the herd immunity threshold. However, the number of susceptible individuals and the opportunities for contact between infectious and susceptible individuals influence the progress of an epidemic. Thus, in addition to vaccination, control of a pandemic may be difficult or impossible to achieve without other public health measures, including wearing face masks and social distancing. This article discusses the factors that may contribute to herd immunity and control of COVID-19 through the availability of effective vaccines and describes how vaccine effectiveness in the community may be lower than that expected. It also discusses how pandemic control in some countries and populations may face vaccine accessibility barriers if market forces strongly regulate the new technologies available, according to the inverse care law.
引用
收藏
页数:7
相关论文
共 43 条
  • [1] New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications
    Abdool Karim, Salim S.
    de Oliveira, Tulio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (19) : 1866 - 1868
  • [2] Albert S, 2020, MARKETWATCH CONVERSA, P15
  • [3] Anderson M, 1992, INFECT DIS HUMANS DY
  • [4] THE CONCEPT OF HERD-IMMUNITY AND THE DESIGN OF COMMUNITY-BASED IMMUNIZATION PROGRAMS
    ANDERSON, RM
    [J]. VACCINE, 1992, 10 (13) : 928 - 935
  • [5] Measles and rubella eradication in the Americas
    Andrus, Jon Kim
    de Quadros, Ciro A.
    Solorzano, Carlos Castillo
    Periago, Mirta Roses
    Henderson, D. A.
    [J]. VACCINE, 2011, 29 : D91 - D96
  • [6] [Anonymous], 2021, BBC NEWS 0410
  • [7] [Anonymous], NEW YORK TIMES
  • [8] The global polio eradication initiative: Lessons learned and prospects for success
    Aylward, Bruce
    Tangermann, Rudolf
    [J]. VACCINE, 2011, 29 : D80 - D85
  • [9] Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
    Bartsch, Sarah M.
    O'Shea, Kelly J.
    Ferguson, Marie C.
    Bottazzi, Maria Elena
    Wedlock, Patrick T.
    Strych, Ulrich
    McKinnell, James A.
    Siegmund, Sheryl S.
    Cox, Sarah N.
    Hotez, Peter J.
    Lee, Bruce Y.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2020, 59 (04) : 493 - 503
  • [10] Equitable and Effective Distribution of the COVID-19 Vaccines - A Scientific and Moral Obligation
    Binagwaho, Agnes
    Mathewos, Kedest
    Davis, Sheila
    [J]. INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2022, 11 (02) : 100 - 102